Adagene Operating Cycle 2011-2026 | ADAG

Annual Operating Cycle Adagene

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	53.8	125	182	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
182	53.8	120

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	4.89	$ 0.89	-0.61 %	$ 6.54 M	China
ACADIA Pharmaceuticals ACAD	332	$ 22.57	1.21 %	$ 3.74 B	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	135	-	-	$ 35.4 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
ChromaDex Corporation CDXC	24.7	-	-0.88 %	$ 598 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Aquestive Therapeutics AQST	223	$ 4.09	-0.37 %	$ 437 M	USA
Arcutis Biotherapeutics ARQT	291	$ 23.2	-0.96 %	$ 2.95 B	USA
Autolus Therapeutics plc AUTL	129	$ 1.48	3.87 %	$ 394 M	Britain
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	127	-	-	$ 546 M	USA
Cardiff Oncology CRDF	294	$ 1.71	-0.58 %	$ 114 M	USA
CTI BioPharma Corp. CTIC	90.1	-	-	$ 1.2 B	USA
BioXcel Therapeutics BTAI	1.66 K	$ 1.07	-1.83 %	$ 13.1 M	USA